Seminar movies

Doctor of Naturopathy, ROBERT MILLER, specializing in the field of genetic-specific nutrition, presents some ground-breaking research related to Lyme disease and why the some patients remain ill for years. One of the confusing situations with Lyme Disease, is that some people respond quickly to treatment, while others cannot tolerate the treatment, or continue to have less than optimal outcomes, Bob Miller will explore why genetic conditions may be a contributing factors to poor detoxification pathways and lowered immunity. He will be presenting the information that was discovered by the NutriGenetic Research Institute’s two studies on the genetic patterns of those with Chronic Lyme, and how nutritional interventions, offering compensating mechanisms, may be supportive of conventional treatment.

We deeply appreciate donations through our donation page. Without donations, we will not be able to continue organizing these seminars.

Part 1:
1.Introduction to how genetics can impact enzyme function
2.Introduction to the “good guys” and bad guys
3.Introduction to the Methylation Map
4.Introduction to the free radical pathway

Part 2:
In this segment we will review the findings of the Phase 1 Lyme study that was recognized as a winner of research at the ILADS conference in Helsinki, Finland in June 2016. We will discuss the pathways that impact Mitochondria Function, Glutamate Excess, and NOS uncoupling We will discuss the nutritional interventions that offer support to these genetic imbalances

Part 3:
1.Iron Dysregulation findings that were found to be significantly higher in the Lyme study, and how this creates Hydroxyl radicals, and then we will discuss nutritional interventions that offers support to these genetic imbalances.
2.Lyme Study Phase II – We will explore the finding of this study, where we expanded the research to 1298 genes and discuss how neurotransmitter variants were the prominent findings, and how this can impact inflammation and immunity
3.If time permits and data is prepared, a brief introduction to Phase III, that is analyzing additional pathways in Glutamate and Glutathione production and utilization.
4. Case Study

Questions and answers

Powerpoint presentation